WASHINGTON — Fifteen Democrats in Congress are seizing on momentum in the field of precision medicine, penning a letter Tuesday to Secretary of Health and Human Services Tom Price urging increased patient access to genetic testing.

The letter was sent on the same day the Personalized Medicine Coalition hosted a congressional briefing, which featured Senator Edward Markey of Massachusetts, a Democrat.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

    • Nice study, but the reality in the US there has actually been a trend away from insurance companies paying for predictive testing. The new regulations require that an ICD-10 disease code be written on every physician written for an ordered test. For example when my doctor ordered a screening aortic ultrasound he had to code it as “aortic aneurysm”. Let’s say you had a severe drug induced hemolytic anemia resulting in a $50,000 hospitalization that might have been prevented by pharmacogenetic screening. The insurer would not balk at paying for the hospitalization buy not pay for the screening test to prevent it.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy